Rx Propellant becomes a part of the Actis portfolio

Rx Propellant has been acquired by Actis – a UK based global investment company for an initial USD 200 million investment in May 2022. This investment places a focus on sustainability in life science clusters in the cities of Hyderabad, Bengaluru and Mumbai.

Read More


Rx Propellant announces the launch of 9 lakh sqft of lab spaces in Hyderabad

Hyderabad, October 18, 2022: India’s leading life sciences infrastructure and cluster developers, Rx Propellant, on Tuesday announced the launch of 9 lakh sqft of lab spaces in Genome Valley of Hyderabad. The foundation stones for two new projects, B-hub and GV1, were laid by Industries & Commerce Minister K.T. Rama Rao.

Know More


Meeting to boost collaboration in life sciences held in Hyderabad 

Hyderabad, February 23, 2023: A meeting seeking to promote collaboration in life sciences and serve as a networking platform for researchers, entrepreneurs and industry professionals was conducted on Thursday at Genome Valley.

Know More


Rx Propellant, Roach Lifescapes to set up life sciences cluster in Bengaluru

Bengaluru, March 15, 2023: Rx Propellant in partnership with Roach Lifescapes, plans to set up a 52-acre campus, Bengaluru Lifesciences Research (BLR) District, in Attibele, Bengaluru. The project comprises lab space modules and built-to-suit flexi factories catering to the biopharma, medtech, agriscience, nutraceutical, and allied sectors.


Know More